Label-Free High-Throughput bioanalytical Technologies

Session Chair - Funded(s)

• WR

  Wolfgang Reindl, PhD

  Principal Scientist
  Boehringer Ingelheim, Baden-Wurttemberg, Germany

Session Chair(s)

• 

  Catherine Tralau-Stewart, PhD

  Senior Director Alliances
  Takeda Pharmaceuticals, California, United States

Presentations:

• 10:00 AM – 10:30 AM

  Development of Fluorescence and Mass Spectrometry Based Detection Assays for assessment of TMPRSS2 inhibition as Potential Treatment of COVID-19
  

  John Janiszewski, MS – NIH/NCATS -

  Jonathan Shrimp, PhD – NCATS/NIH
• 10:30 AM – 11:00 AM

  High throughput covalent fragment screening with MALDI mass spectrometry
  

  Don D. Nguyen, PhD – Merck
• 11:00 AM – 11:30 AM

  Compound Confirmation using Acoustic Ejection-Open Port Interface Mass Spectrometry (AE-OPI-MS) Analysis in Support of High-Throughput Screening Activities
  

  Jefferson Chin, BSc, MBA – AssayQuant Technologies